Hospitalizations following living donor nephrectomy in the United States
- PMID: 24458071
- PMCID: PMC3913232
- DOI: 10.2215/CJN.03820413
Hospitalizations following living donor nephrectomy in the United States
Abstract
Background and objectives: Living donors represented 43% of United States kidney donors in 2012. Although research suggests minimal long-term consequences of donation, few comprehensive longitudinal studies for this population have been performed. The primary aims of this study were to examine the incidence, risk factors, and causes of rehospitalization following donation.
Design, setting, participants, & measurements: State Inpatient Databases (SID) compiled by the Agency for Healthcare Research and Quality were used to identify living donors in four different states between 2005 and 2010 (n=4524). Multivariable survival models were used to examine risks for rehospitalization, and patient characteristics were compared with data from the Scientific Registry of Transplant Recipients (SRTR). Outcomes among patients undergoing appendectomy (n=200,274), cholecystectomy (n=255,231), and nephrectomy for nonmetastatic carcinoma (n=1314) were contrasted.
Results: The study population was similar to United States donors (for SRTR and SID, respectively: mean age, 41 and 41 years; African Americans, 12% and 10%; women, 60% and 61%). The 3-year incidence of rehospitalization following donation was 11% for all causes and 9% excluding pregnancy-related hospitalizations. After censoring of models for pregnancy-related rehospitalizations, older age (adjusted hazard ratio [AHR], 1.02 per year; 95% confidence interval [95% CI], 1.01 to 1.03), African American race (AHR, 2.16; 95% CI, 1.54 to 3.03), depression (AHR, 1.88; 95% CI, 1.12 to 3.14), hypothyroidism (AHR, 1.63; 95% CI, 1.06 to 2.49), and longer initial length of stay were related to higher rehospitalization rates among donors. Compared with living donors, adjusted risks for rehospitalizations were greater among patients undergoing appendectomy (AHR, 1.58; 95% CI, 1.42 to 1.75), cholecystectomy (AHR, 2.25; 95% CI, 2.03 to 2.50), and nephrectomy for nonmetastatic carcinoma (AHR, 2.95; 95% CI, 2.58 to 3.37). Risks for rehospitalizations were higher among African Americans than whites in each of the surgical groups.
Conclusions: The SID is a valuable source for evaluating characteristics and outcomes of living kidney donors that are not available in traditional transplant databases. Rehospitalizations following donor nephrectomy are less than seen with other comparable surgical procedures but are relatively higher among donors who are older, are African American, and have select comorbid conditions. The increased risks for rehospitalizations among African Americans are not unique to living donation.
Figures



Comment in
-
Rehospitalization after living kidney donation.Clin J Am Soc Nephrol. 2014 Feb;9(2):227-8. doi: 10.2215/CJN.12701213. Epub 2014 Jan 23. Clin J Am Soc Nephrol. 2014. PMID: 24458083 Free PMC article. No abstract available.
Similar articles
-
Comorbidity burden and perioperative complications for living kidney donors in the United States.Clin J Am Soc Nephrol. 2013 Oct;8(10):1773-82. doi: 10.2215/CJN.12311212. Epub 2013 Sep 26. Clin J Am Soc Nephrol. 2013. PMID: 24071651 Free PMC article.
-
Race, Relationship and Renal Diagnoses After Living Kidney Donation.Transplantation. 2015 Aug;99(8):1723-9. doi: 10.1097/TP.0000000000000733. Transplantation. 2015. PMID: 25905980 Free PMC article.
-
Gout after living kidney donation: correlations with demographic traits and renal complications.Am J Nephrol. 2015;41(3):231-40. doi: 10.1159/000381291. Epub 2015 Apr 17. Am J Nephrol. 2015. PMID: 25896309 Free PMC article.
-
Risks and outcomes of living donation.Adv Chronic Kidney Dis. 2012 Jul;19(4):220-8. doi: 10.1053/j.ackd.2011.09.005. Adv Chronic Kidney Dis. 2012. PMID: 22732041 Free PMC article. Review.
-
Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.Clin J Am Soc Nephrol. 2019 Apr 5;14(4):597-608. doi: 10.2215/CJN.11220918. Epub 2019 Mar 11. Clin J Am Soc Nephrol. 2019. PMID: 30858158 Free PMC article. Review.
Cited by
-
Renal and cardiac assessment of living kidney donor candidates.Nat Rev Nephrol. 2017 Jul;13(7):420-428. doi: 10.1038/nrneph.2017.43. Epub 2017 Apr 3. Nat Rev Nephrol. 2017. PMID: 28366942 Review.
-
Follow-up Care of Living Kidney Donors in Alberta, Canada.Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018. Can J Kidney Health Dis. 2018. PMID: 30083366 Free PMC article.
-
Assessment of cognitive functioning after living kidney donation: A cross-sectional pilot study.PLoS One. 2022 Feb 25;17(2):e0264284. doi: 10.1371/journal.pone.0264284. eCollection 2022. PLoS One. 2022. PMID: 35213618 Free PMC article. Clinical Trial.
-
Risk for cancer in living kidney donors and recipients.J Cancer Res Clin Oncol. 2018 Mar;144(3):543-550. doi: 10.1007/s00432-018-2590-z. Epub 2018 Jan 22. J Cancer Res Clin Oncol. 2018. PMID: 29356887 Free PMC article. Review.
-
Validation of Living Donor Nephrectomy Codes.Can J Kidney Health Dis. 2018 Apr 9;5:2054358118760833. doi: 10.1177/2054358118760833. eCollection 2018. Can J Kidney Health Dis. 2018. PMID: 29662679 Free PMC article.
References
-
- Organ Procurement and Transplantation Network. Donors recovered in the U.S. by donor type. Available at: http://optn.transplant.hrsa.gov/data/ August 14, 2013.
-
- Gill JS, Schaeffner E, Chadban S, Dong J, Rose C, Johnston O, Gill J: Quantification of the early risk of death in elderly kidney transplant recipients. Am J Transplant 13: 427–432, 2013 - PubMed
-
- Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, McBride MA, Montgomery RA: Perioperative mortality and long-term survival following live kidney donation. JAMA 303: 959–966, 2010 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical